168 related articles for article (PubMed ID: 36768603)
1. Cytotoxic Effects of Darinaparsin, a Novel Organic Arsenical, against Human Leukemia Cells.
Yuan B; Kikuchi H; Li J; Kawabata A; Yao K; Takagi N; Okazaki M
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768603
[TBL] [Abstract][Full Text] [Related]
2. The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models.
Ravi D; Bhalla S; Gartenhaus RB; Crombie J; Kandela I; Sharma J; Mazar A; Evens AM
Clin Cancer Res; 2014 Dec; 20(23):6023-33. PubMed ID: 25316819
[TBL] [Abstract][Full Text] [Related]
3. A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines.
Diaz Z; Mann KK; Marcoux S; Kourelis M; Colombo M; Komarnitsky PB; Miller WH
Leukemia; 2008 Oct; 22(10):1853-63. PubMed ID: 18633430
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
Li Y; Qu X; Qu J; Zhang Y; Liu J; Teng Y; Hu X; Hou K; Liu Y
Cancer Lett; 2009 Nov; 284(2):208-15. PubMed ID: 19457607
[TBL] [Abstract][Full Text] [Related]
5. Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line.
Matulis SM; Morales AA; Yehiayan L; Croutch C; Gutman D; Cai Y; Lee KP; Boise LH
Mol Cancer Ther; 2009 May; 8(5):1197-206. PubMed ID: 19417148
[TBL] [Abstract][Full Text] [Related]
6. Darinaparsin: a novel organic arsenical with promising anticancer activity.
Mann KK; Wallner B; Lossos IS; Miller WH
Expert Opin Investig Drugs; 2009 Nov; 18(11):1727-34. PubMed ID: 19780704
[TBL] [Abstract][Full Text] [Related]
7. Darinaparsin: solid tumor hypoxic cytotoxin and radiosensitizer.
Tian J; Zhao H; Nolley R; Reese SW; Young SR; Li X; Peehl DM; Knox SJ
Clin Cancer Res; 2012 Jun; 18(12):3366-76. PubMed ID: 22535156
[TBL] [Abstract][Full Text] [Related]
8. Zerumbone, a bioactive sesquiterpene, induces G2/M cell cycle arrest and apoptosis in leukemia cells via a Fas- and mitochondria-mediated pathway.
Xian M; Ito K; Nakazato T; Shimizu T; Chen CK; Yamato K; Murakami A; Ohigashi H; Ikeda Y; Kizaki M
Cancer Sci; 2007 Jan; 98(1):118-26. PubMed ID: 17129359
[TBL] [Abstract][Full Text] [Related]
9. Darinaparsin is a multivalent chemotherapeutic which induces incomplete stress response with disruption of microtubules and Shh signaling.
Mason TA; Kolobova E; Liu J; Roland JT; Chiang C; Goldenring JR
PLoS One; 2011; 6(11):e27699. PubMed ID: 22110729
[TBL] [Abstract][Full Text] [Related]
10. The novel synthesized 2-(3-(methylamino)phenyl)-6-(pyrrolidin-1-yl)quinolin-4-one (Smh-3) compound induces G2/M phase arrest and mitochondrial-dependent apoptotic cell death through inhibition of CDK1 and AKT activity in HL-60 human leukemia cells.
Huang SM; Yang JS; Tsai SC; Chen MH; Hsu MH; Lin HY; Chou LC; Chinag JH; Lee KH; Huang LJ; Kuo SC
Int J Oncol; 2011 May; 38(5):1357-64. PubMed ID: 21344160
[TBL] [Abstract][Full Text] [Related]
11. Selective induction of G2/M arrest and apoptosis in HL-60 by a potent anticancer agent, HMJ-38.
Yang JS; Hour MJ; Kuo SC; Huang LJ; Lee MR
Anticancer Res; 2004; 24(3a):1769-78. PubMed ID: 15274354
[TBL] [Abstract][Full Text] [Related]
12. Delphinidin induces cytotoxicity and potentiates cytocidal effect in combination with arsenite in an acute promyelocytic leukemia NB4 cell line.
Yuan B; Okusumi S; Yoshino Y; Moriyama C; Tanaka S; Hirano T; Takagi N; Toyoda H
Oncol Rep; 2015 Jul; 34(1):431-8. PubMed ID: 25954945
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological profile and clinical study results of darinaparsin (DARVIAS
Yao K; Sonehara Y; Nagahama F
Nihon Yakurigaku Zasshi; 2023; 158(5):408-418. PubMed ID: 37673618
[TBL] [Abstract][Full Text] [Related]
14. N-benzyl-N-methyldecan-1-amine, a phenylamine derivative isolated from garlic cloves, induces G2/M phase arrest and apoptosis in U937 human leukemia cells.
Jeong JW; Park S; Park C; Chang YC; Moon DO; Kim SO; Kim GY; Cha HJ; Kim HS; Choi YW; Kim WJ; Yoo YH; Choi YH
Oncol Rep; 2014 Jul; 32(1):373-81. PubMed ID: 24859825
[TBL] [Abstract][Full Text] [Related]
15. Caffeine induces G2/M arrest and apoptosis via a novel p53-dependent pathway in NB4 promyelocytic leukemia cells.
Ito K; Nakazato T; Miyakawa Y; Yamato K; Ikeda Y; Kizaki M
J Cell Physiol; 2003 Aug; 196(2):276-83. PubMed ID: 12811820
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells.
Chiu SJ; Lee YJ; Hsu TS; Chen WS
Chem Biol Interact; 2009 Dec; 182(2-3):173-82. PubMed ID: 19735649
[TBL] [Abstract][Full Text] [Related]
17. Phenethyl isothiocyanate induces DNA damage-associated G2/M arrest and subsequent apoptosis in oral cancer cells with varying p53 mutations.
Yeh YT; Yeh H; Su SH; Lin JS; Lee KJ; Shyu HW; Chen ZF; Huang SY; Su SJ
Free Radic Biol Med; 2014 Sep; 74():1-13. PubMed ID: 24952138
[TBL] [Abstract][Full Text] [Related]
18. Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1.
Drago-Ferrante R; Santulli A; Di Fiore R; Giuliano M; Calvaruso G; Tesoriere G; Vento R
Int J Oncol; 2008 Oct; 33(4):677-87. PubMed ID: 18813780
[TBL] [Abstract][Full Text] [Related]
19. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
[TBL] [Abstract][Full Text] [Related]
20. The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells.
Garnier N; Petruccelli LA; Molina MF; Kourelis M; Kwan S; Diaz Z; Schipper HM; Gupta A; del Rincon SV; Mann KK; Miller WH
Leukemia; 2013 Nov; 27(11):2220-8. PubMed ID: 23426167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
